We are live on ! Find out more
IBER.U

Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant
IBER.U

Delisted

IBER.U was delisted on the 1st of March, 2023.

Back to rankings

60 hedge funds and large institutions have $120M invested in Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant in 2021 Q1 according to their latest regulatory filings, with 60 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
60
Holders Change
+60
Holders Change %
–
% of All Funds
1.05%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
60
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
HP
Hartree Partners
New York
+$12.8M
2
MF
Magnetar Financial
Illinois
+$8.03M
3
Citadel Advisors
Citadel Advisors
Florida
+$7.75M
4
Millennium Management
Millennium Management
New York
+$5.25M
5
PAMP
Polar Asset Management Partners
Ontario, Canada
+$5M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Alyeska Investment Group
26
Alyeska Investment Group
Illinois
$1.48M +$1.5M +150,000 New
SSA
27
Schonfeld Strategic Advisors
New York
$1.48M +$1.5M +150,000 New
BCM
28
Basso Capital Management
Connecticut
$1.33M +$1.35M +135,404 New
CCM
29
Context Capital Management
California
$1.13M +$1.15M +115,053 New
FTCM
30
Fir Tree Capital Management
New York
$986K +$1,000K +100,000 New
SMA
31
Sage Mountain Advisors
Georgia
$922K +$935K +93,470 New
Walleye Trading
32
Walleye Trading
New York
$789K +$800K +80,000 New
AA
33
AQR Arbitrage
Connecticut
$740K +$750K +75,000 New
WA
34
Whitebox Advisors
Minnesota
$740K +$750K +75,000 New
WRBC
35
W.R. Berkley Corp
Connecticut
$678K +$688K +68,776 New
HF
36
HRT Financial
New York
$640K +$650K +64,980 New
AM
37
Ampfield Management
New York
$593K +$601K +60,100 New
Goldman Sachs
38
Goldman Sachs
New York
$540K +$548K +54,762 New
HP
39
Hound Partners
New York
$493K +$500K +50,000 New
Jane Street
40
Jane Street
New York
$493K +$500K +50,000 New
PI
41
PEAK6 Investments
Illinois
$493K +$500K +50,000 New
DMK
42
David M. Knott
$355K +$360K +36,000 New
Susquehanna International Group
43
Susquehanna International Group
Pennsylvania
$290K +$294K +29,367 New
LCM
44
Landscape Capital Management
New Jersey
$254K +$257K +25,713 New
CCM
45
CAAS Capital Management
New York
$247K +$250K +25,000 New
DIG
46
DeepCurrents Investment Group
New York
$247K +$250K +25,000 New
D.E. Shaw & Co
47
D.E. Shaw & Co
New York
$247K +$250K +25,000 New
Capstone Investment Advisors
48
Capstone Investment Advisors
New York
$246K +$250K +25,000 New
Janus Henderson Group
49
Janus Henderson Group
United Kingdom
$198K +$200K +20,000 New
BCM
50
Brigade Capital Management
New York
$197K +$200K +20,000 New
1
2
3

IBER.U Hedge Fund Activity: Q1 2021 in Review

60 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant (IBER.U) for Q1 2021, worth a combined $120M.

Buyers outnumbered sellers: 60 funds opened new IBER.U positions and 0 closed out — a net gain of 60 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Hartree Partners, opening a new position worth an estimated $12.8M.

  • 60 institutional investors held Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant (IBER.U) as of Q1 2021, up from 0 in Q4 2020.
  • Funds reported $120M of Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant stock for Q1 2021.
  • 60 funds opened new Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant positions in Q1 2021 and 0 closed out, a net change of +60 holders.
  • The largest Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant buyer in Q1 2021 was Hartree Partners, an estimated $12.8M added.

Based on aggregated 13F filings for Q1 2021.